Other common mutations in CRC are APC and p53 loss‐of‐function mutations, whereas the top mutations in bladder cancer are found in the FGFR3, PIK3CA, KDM6A and TP53 genes. This evidence concerns the gene TP53 and colorectal carcinoma.